Streetbeat News

Analyst Ratings

HIBB

Telsey Advisory Group analyst Joseph Feldman maintains an Outperform rating on Hibbett (NASDAQ:HIBB) but lowers the price target from $80 to $70.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 9:07 am

GHL

JMP Securities analyst Devin Ryan has downgraded Greenhill & Co (NYSE:GHL) from Market Outperform to Market Perform.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 8:51 am

CMRX

Baird analyst Joel Beatty has initiated coverage on Chimerix (NASDAQ:CMRX) with an Outperform rating and a price target of $7.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 8:30 am

RAIN

Oppenheimer analyst Jeff Jones has downgraded Rain Oncology (NASDAQ:RAIN) from Outperform to Perform.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 8:29 am

RAIN

EF Hutton analyst Tony Butler downgrades Rain Oncology (NASDAQ:RAIN) from Buy to Hold and lowers the price target from $16 to $5.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 8:27 am

VECT

Credit Suisse analyst Tiago Fauth downgraded VectivBio Holding (NASDAQ:VECT) from Outperform to Neutral and lowered the price target from $22 to $17.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 8:23 am

GHL

Keefe, Bruyette & Woods analyst Matthew Moon has upgraded Greenhill & Co (NYSE:GHL) from Underperform to Market Perform and raised the price target from $6.5 to $15.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 8:21 am

IMVT

Chardan Capital analyst Matthew Barcus maintains a Buy rating on Immunovant (NASDAQ:IMVT) and raises the price target from $21 to $32.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 8:19 am

NVGS

Jefferies analyst Omar Nokta maintains a Buy rating on Navigator Holdings (NYSE:NVGS) and raises the price target from $16 to $18.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 8:14 am

FBRT

Raymond James analyst Stephen Laws maintains an Outperform rating on Franklin BSP Realty Trust (NYSE:FBRT) and raises the price target from $13.5 to $14.5.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 8:13 am